Our forward-looking statements are also subject to a large number of risks and uncertainties, which may affect our short-term and long-term performance. About InnoCare InnoCare (HKEX: 09969; SSE: 688428) is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases with unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, Hong Kong, and United States.  1 The financial figures in this article are based on Hong Kong Financial Reporting Standards 2 Include cash and bank balances, other financial assets balance and interest receivables balance. 3 iHealthcareAnalyst, Inc., Oct. 3, 2023 4 Cancer-free